Preventing C. diff recurrence with a bile acid supplement
Part of Infections clinical trials.
This trial tests whether adding a bile acid supplement (ursodeoxycholic acid) to standard antibiotics can help prevent a repeat C. diff infection. It is for people who have already had a C. diff infection and have at least one factor that increases their risk of it coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have tested positive for C. diff toxin
- You are currently being treated with an antibiotic like metronidazole (Flagyl), vancomycin, or fidaxomicin
- You have at least one risk factor for the infection returning (such as being older, having a weak immune system, or recent hospitalization)
- You can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new antibody (AZD5148) to prevent C. diff infection from coming back. If you have a current C. diff infection and are being treated with antibiotics, you may be able to join.
This study tests whether specific lifestyle changes during treatment for C. difficile infection (a serious gut bacteria infection) can help prevent it from coming back. You'll receive standard antibiotic treatment and follow a controlled diet while researchers track your recovery.
This study tests a new live bacteria product (EXL01) given with vancomycin to prevent C. diff from coming back. It is for people who have already had C. diff two or more times and are at high risk of another infection.
This trial tests whether taking vancomycin by mouth can prevent another C. diff infection when you need to take other antibiotics. It’s for patients who recently had C. diff and are about to start a new antibiotic course.
This study compares two medicines, fidaxomicin and vancomycin, to see which one is better at preventing C. diff infection in people with inflammatory bowel disease who are having a colonoscopy.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.